The major emendations in the final versions can be summarized as follows: #The most frequent modification is expansion of the original material.
The most frequent modification was the choice of chemotherapy regimen and the less frequent modification was the use of chemotherapy.
In the experimental group, for breast cancer the most frequent modification of practice concerned less extensive follow-up after treatment.
The most frequent modification was the collection of information on the average duration (in minutes) for mild, moderate, and strenuous LTPA (e.g., [ 65– 65]).
For patients who initiated second-line cART with a detectable HIV RNA, the most frequent modification was from NNRTI to a boosted PI-based (65%) cART (Table 1).
The most frequent modification (72.3%%) was the collection of information on the average duration (minutes/week) for mild, moderate and strenuous LTPA bouts.
The most frequent modification on 3' and 5' ends were DEL (66 and 71%%, respectively; Fig. 2a) with dominant DEL of 1 nt (44 and 80%% of deletions, respectively; Fig. 2b).
Modifications were most often motivated by mycological results, and de-escalation was the most frequent change.
(65) Binary Cr-DNA adducts are the most frequent DNA modifications in the in vitro reductions of Cr VI).
The most frequent posttranslational modifications (PTM) we identified were as follows: mono-oxidation, pyrrolidinone, 4-hydroxynonenal (HNE), carboxymethyl, carboxethyl, glutamic semialdehyde (Glu SA), and 3-deoxyglucosone.
